Market closedNon-fractional

Poseida Therapeutics/PSTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Poseida Therapeutics

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Ticker

PSTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

335

PSTX Metrics

BasicAdvanced
$285M
Market cap
-
P/E ratio
-$1.18
EPS
0.53
Beta
-
Dividend rate
$285M
0.53
2.557
2.485
92.874
99.961
-12.88%
-24.85%
-89.91%
3.301
3.36
3.6
-3.797
-40.82%
104.41%
-25.91%

What the Analysts think about PSTX

Analyst Ratings

Majority rating from 5 analysts.
Buy

PSTX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-86.12% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$28M
12.85%
Net income
-$24M
-4.35%
Profit margin
-86.12%
-15.24%

PSTX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 40.48%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.32
-$0.35
-$0.27
-$0.25
-
Expected
-$0.53
-$0.29
-$0.39
-$0.42
-$0.41
Surprise
-39.39%
19.66%
-30.05%
-40.48%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Poseida Therapeutics stock?

Poseida Therapeutics (PSTX) has a market cap of $285M as of July 06, 2024.

What is the P/E ratio for Poseida Therapeutics stock?

The price to earnings (P/E) ratio for Poseida Therapeutics (PSTX) stock is 0 as of July 06, 2024.

Does Poseida Therapeutics stock pay dividends?

No, Poseida Therapeutics (PSTX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Poseida Therapeutics dividend payment date?

Poseida Therapeutics (PSTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Poseida Therapeutics?

Poseida Therapeutics (PSTX) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Poseida Therapeutics stock

Buy or sell Poseida Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing